Study Document
Issues Surrounding the Importation of Prescription Drugs in the US Case Study
Pages:2 (609 words)
Sources:1
Document Type:Case Study
Document:#11772401
CASE STUDY: IMPORTING DRUGS TO US Case Study: Importing Drugs to US7-3: Should the United States legalize the importation of lower cost pharmaceuticals? If so, should this apply to individual consumers, pharmacies, or other entities?The US should legalize the importation of lower-cost pharmaceuticals from selected countries with testing and licensure requirements similar to those of the FDA. Strict conformity to US standards for handling and manufacturing prescriptions would ensure that Americans are protected from unsafe medication. Importation would also lower drug prices for American consumers as assessments have indicated that prescription drugs in countries like Canada retail at between 40 and 60 percent less than in the US (XXX). Ultimately, this would result in significant cost savings for individual customers as well as private and public payers. For instance, the state of Florida projects that its importation program would save the state between $80 and $150 million in prescription expenses annually (Freed et al., 2021).Current importation laws only allow pharmaceutical companies to import drugs into the US. In essence, this means that manufacturers set their own drug prices in the American market. However, this creates a monopoly among manufacturers that limits price competition and encourages price gouging (XXX). For instance, the case demonstrates…
…been realized.The FDA could set the standard that only drugs that are currently marketed in the US would be eligible for importation. Current law excludes certain drugs and biological products from importation including drugs inhaled during surgery, intravenously injected drugs, infused drugs, biological products such as insulin, controlled substances, and drugs such as opioids that are classified under the FDAs Risk Mitigation and Evaluation Strategies (REMS) for posing serious safety concerns (Freed et al., 2021). These drugs could be excluded from importation, due to their associated safety concerns. Any other drugs that is currently marketed in the US market could be imported for…
Related Documents
Study Document
Direct to Consumer Advertising History of Drug
Direct to Consumer Advertising HISTORY OF DRUG ADVERTISING THE DTC ADVERTISING PHENOMENON CREATING DEMAND DECEPTIVE ADVERTISING - A WOLF IN SHEEP'S CLOTHING CAUSE OF DEATH PROFIT UTILIZATION, PRICING, AND DEMOGRAPHICS LEGISLATION, POLITICS AND PATENTS LEGISLATIVE INITIATIVES REGARDING DTC RECALLED and/or DEADLY DRUGS In order to provide the most efficient method of evaluation, the study will utilize existing stores of qualitative and quantitative data from reliable sources, such as U.S. Government statistical references, University studies, and the studies and publications of non-profit
Study Document
Obama Administration's Health Care Plan
While people who work with these kinds of issues can present their best guesses, they cannot actually provide proof that the Obama Administration's health care plan is good or bad, or how much it will cost. The 'if only' propositions that are in much of the plan tend to make statisticians and fact-checkers nervous, simply because of the nature of these kinds of propositions -- they rely on the
Study Document
Pneumonia Readmissions Among Nursing Home Residents
Topic: Pneumonia readmissions among nursing home residents 65 years and older in the United States of America. Backdrop of the dilemma Pneumonia remains an extreme health condition in America. It accounts for roughly 1 million medical-center admissions and over 50,000 fatalities yearly. Roughly ten to twenty percent of pneumonia occurrences need admittance to the Intensive Care Unit or ICU. Moreover, pneumonia accounts for near to 140,000 medical-center readmissions each year, pricing in